CoChat

Benzodiazepine tapering: A prospective study

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Benzodiazepines (BZD) are the most widely used sedative-hypnotics, and evidence is rapidly accumulating suggesting potential BZD dependence, association of chronic use with adverse effects and a definite abstinence syndrome produced by withdrawal. AIMS: The present investigation followed prospectively long-term BZD users over 1 year following graded BZD withdrawal in terms of clinical and withdrawal symptoms. METHODS: Clinical symptoms were measured by the Comprehensive Psychopathological Rating Scale (CPRS) and by the Newcastle Anxiety and Depression Diagnostic Index (NADDI) in a sample of BZD users over a 50-week period following graded BZD withdrawal. RESULTS: The results showed that the frequency and severity of clinical symptomatology measured by both scales significantly decreased over time. A detailed analysis of possible patterns of symptoms on both scales revealed four patterns: 1) a gradual decrease over the 50-week time period; 2) an increase in the severity of symptoms at the onset of tapering and a decrease in severity post-tapering; 3) an increase in the severity of symptoms 4 weeks after the cessation of BZD tapering; and 4) no change over the 50-week time period. Rate of BZD withdrawal was associated with CPRS ratings of global illness at admission and at end of treatment, but was not associated with duration or dosage of BZDs, type of BZD, prescriptive and/or non-prescriptive drug use prior to admission, marital status, sex or age. CONCLUSIONS: The results of the present study provide a detailed picture of the pattern of symptoms, their time course and multidimensional determinants of the BZD withdrawal symptoms.

Overview

Integrity signals

Registry

Crossref · 10.3109/08039481003624173

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 5

  1. Balter MB, 1991, J Clin Psychiat, 52, 16
  2. O’Brien CP, 2005, J Clin Psychiatry, 66, 28
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edition-revised. Washington, DC: The American Psychiatric Association; 1987.
  4. Schuetz H, 1982, Aerztliches Laborator, 28, 117
  5. Vicens C, 2006, Br J Gen Pract, 56, 958

Cited by

Metadata

Authors
Vikander, B., Koechling, U. M., Borg, S., Tönne, U., & Hiltunen, A. J.
Affiliations
  • Karolinska Institutet (SE)
  • Karlstad University (SE)
Corresponding author
Hiltunen, Arto J.
Venue
Nordic Journal of Psychiatry
Published
2010-07-15
Volume
64
Issue
4
Pages
273-282
ISSN
  • 0029-1455 (ISSN-L)
  • 0803-9488
  • 1502-4725
OpenAlex
W2103482466
Cited by
37
References
45
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 3
FWCI
1.16
Type
journal article
Language
en
Open access
closed
Locations
  • Nordic Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
benzodiazepine withdrawal, benzodiazepine tapering, withdrawal symptoms, benzodiazepine dependence, sedative-hypnotic drugs, Comprehensive Psychopathological Rating Scale
MeSH terms
Adolescent, Adult, Anxiety Disorders, Benzodiazepines, Depressive Disorder, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Hypnotics and Sedatives, Male, Middle Aged, Prospective Studies, Severity of Illness Index, Substance Withdrawal Syndrome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.